Acambis
Ian Garland joins Acambis as new CEO
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 26th, 2007
As previously announced, Acambis' previous CEO, Gordon Cameron, continues as a Board Member until 1 June 2007 to facilitate the transition.
Acambis will publish its financial results for the three months ended 31 March 2007 on Thursday, 10 May. A conference call for analysts and investors will be co-hosted by Ian Garland and Acting Chief Financial Officer, Elizabeth Brown.
Keywords: , Acambis, Biotechnology Business,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AARP
AARP Rolls Up Their Sleeves Nationwide, Gives Back to Local Communities - Abbott
Abbott Highlights Strong Performance in Corporate Social Responsibility in 2006 Global Citizenship Report - Abraxis BioScience, Inc.
Abraxis BioScience Reports First Quarter 2007 Revenue of $212.2 Million Versus $144.5 Million in Prior Year Period - Abt Associates
Abt Associates' Richard A. Kulka Elected President-elect of American Association for Public Opinion Research - Abt Associates
Constantin Abarbieritei To Lead Abt Associates' International Economic Growth Division - Access Communications, LLC
Access Communications, LLC, Enters New Era of Growth - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
